| RS2147537859 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147537887 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147537918 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147538127 |
AR
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2147538169 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538369 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147538462 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS2147538465 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538605 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538759 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538796 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538807 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538910 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538918 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147538939 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539018 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539047 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539327 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539361 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539378 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539395 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539571 |
PCDH19
|
Health Risk |
Likely pathogenic |
Bilateral tonic-clonic seizure, Bilateral tonic-clonic seizure |
| RS2147539591 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539848 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147539926 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540049 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540086 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540245 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540246 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147540261 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540378 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147540431 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540480 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS2147540489 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147540518 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540522 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540656 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147540748 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540751 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540836 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147540838 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147540901 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147540985 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS2147541121 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147541270 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147541358 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147541373 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147541401 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147541704 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147541733 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147541749 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542056 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542217 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542235 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS2147542264 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542293 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542320 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542709 |
PCDH19
|
Health Risk |
Likely pathogenic |
PCDH19-related epilespy, PCDH19-related epilespy |
| RS2147542719 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542837 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147542870 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147543046 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147545316 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147545812 |
HNF1B
|
Health Risk |
Pathogenic |
— |
| RS2147551714 |
PLS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bone mineral density quantitative trait locus 18, Bone mineral density quantitative trait locus 18 |
| RS2147551760 |
PLS3
|
Health Risk |
Likely pathogenic |
Congenital diaphragmatic hernia, Hernia |
| RS2147551767 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2147552254 |
TEX11
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS2147552486 |
HNF1B
|
Health Risk |
Pathogenic |
— |
| RS2147553451 |
HNF1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Type 2 diabetes mellitus, Nonpapillary renal cell carcinoma |
| RS2147553490 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS2147557663 |
DMD
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2147558029 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147558436 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2147560185 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2147562704 |
IGBP1
|
Health Risk |
Pathogenic |
Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome, Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome |
| RS2147573600 |
AMELX
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1E, Amelogenesis imperfecta type 1E |
| RS2147575564 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS2147577444 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2147581521 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147582103 |
CLCN5
|
Health Risk |
Pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2147585338 |
ALG12
|
Health Risk |
Pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation |
| RS2147585558 |
PLS3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147585672 |
PLS3
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2147585800 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2147586886 |
PLS3
|
Health Risk |
Pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS2147590595 |
PLS3
|
Health Risk |
Pathogenic |
Postmenopausal osteoporosis, Nonpapillary renal cell carcinoma |
| RS2147590837 |
HDAC8
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2147594126 |
CLCN5
|
Health Risk |
Pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2147594216 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2147594243 |
CLCN5
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatemic rickets, X-linked recessive |
| RS2147594453 |
OPHN1
|
Health Risk |
Pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS2147595436 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2147595542 |
HDAC8
|
Health Risk |
Likely pathogenic |
— |
| RS2147596542 |
CLCN5
|
Health Risk |
Pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2147598858 |
HNF1B
|
Health Risk |
Likely pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS2147600340 |
TBX22
|
Health Risk |
Likely pathogenic |
— |
| RS2147603053 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147603245 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147604021 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |